Last reviewed · How we verify
Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole
Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole is a Small molecule drug developed by Fu Jen Catholic University Hospital. It is currently FDA-approved.
At a glance
| Generic name | Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole |
|---|---|
| Sponsor | Fu Jen Catholic University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy (PHASE4)
- A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile (NA)
- Helicobacter Pylori Eradication Study (PHASE4)
- A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication (PHASE4)
- Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy (NA)
- Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication (PHASE3)
- One Sequencing Find All for Helicobacter Pylori Infection
- Dexlansoprazole MR-Based Concomitant Quadruple Therapy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole CI brief — competitive landscape report
- Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole updates RSS · CI watch RSS
- Fu Jen Catholic University Hospital portfolio CI
Frequently asked questions about Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole
What is Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole?
Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole is a Small molecule drug developed by Fu Jen Catholic University Hospital.
Who makes Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole?
Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole is developed and marketed by Fu Jen Catholic University Hospital (see full Fu Jen Catholic University Hospital pipeline at /company/fu-jen-catholic-university-hospital).
What development phase is Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole in?
Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole is FDA-approved (marketed).